The Tisch Cancer Institute is a National Cancer Institute-designated cancer center with a mission to advance basic, clinical and population health cancer research to prevent cancer in healthy individuals and improve the lives of cancer patients and their families in our diverse communities. To accomplish this mission, the TCI has developed collaborative research programs that strive to translate discoveries to new therapies and to develop new prevention and delivery strategies with priority given to cancers affecting our catchment area. With support from the Cancer Center Support Grant (CCSG), TCI develops and fosters a dynamic team of scientists, clinical investigators and administrators and provides the research infrastructure support needed to spur new cancer discoveries and improve the outcomes of cancer patients and their families.
Cancer Clinical Investigation
The goal of the Cancer Clinical Investigation Program is to develop new treatment approaches to cancer by translating discoveries into therapeutic trials.
The goal of the Cancer Immunology Program is to identify mechanisms underlying the suppression of anti-tumor immunity in order to inform development of effective immunotherapies.
The goal of the Cancer Mechanisms Program is to understand the biology of cancer cell development and proliferation, and identify candidate therapeutics that target biological pathways.
Cancer Prevention and Control
The goal of the Cancer Prevention and Control Program is to reduce the burden of cancer incidence, mortality, and disparities in cancer risks and outcomes.